Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Universitätsklinik für Innere Medizin

Klinische Abteilung für Onkologie

SCI/PUBMED gelistet | alle Publikationstypen | Gesamt nach Jahr und Erstautor | MUG-Autor*innen |

** = Publikationen gelistet in SCI/SSCI/Pubmed

Beiträge in Fachzeitschriften

** Absenger, G Resistance to epidermal growth factor receptor tyrosine kinase inhibitors in mutated non-small cell lung cancer: new avenues and strategies to overcome resistance
MEMO-MAG EUR MED ONC. 2019; 12(2): 128-135. Doi: 10.1007/s12254-019-0488-3
Web of Science FullText FullText_MUG

 

** Balic, M; Hilbe, W; Gusel, S; Fiegl, M; Ludwig, H; Mayrbaurl, B; Thaler, J; Samonigg, H; Hegenbarth, K; Eisner, F; Mlineritsch, B; Greil, R; Schandl, MJ; Weltermann, A; Petzer, A; Fuchs, D; Stangl, W; Krippl, P; Stauder, R; Stoger, H Prevalence of comorbidity in cancer patients scheduled for systemic anticancer treatment in Austria A cross-sectional multicentre observational study
MEMO-MAG EUR MED ONC. 2019; Doi: 10.1007/s12254-019-00542-7 [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Balic, M; Thomssen, C; Würstlein, R; Gnant, M; Harbeck, N St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment.
Breast Care (Basel). 2019; 14(2):103-110 Doi: 10.1159/000499931 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Barth, DA; Riedl, JM; Posch, F; Smolle, MA; Kasparek, AK; Niedrist, T; Szkandera, J; Stöger, H; Pichler, M; Stotz, M; Gerger, A Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study.
Clin Transl Oncol. 2019; 21(8):1034-1043 Doi: 10.1007/s12094-019-02037-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Barth, DA; Slaby, O; Klec, C; Juracek, J; Drula, R; Calin, GA; Pichler, M Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma.
Cancers (Basel). 2019; 11(10): Doi: 10.3390/cancers11101580 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Callegaro, D; Miceli, R; Bonvalot, S; Ferguson, PC; Strauss, DC; van Praag, VVM; Levy, A; Griffin, AM; Hayes, AJ; Stacchiotti, S; Pèchoux, CL; Smith, MJ; Fiore, M; Tos, APD; Smith, HG; Catton, C; Szkandera, J; Leithner, A; van de Sande, MAJ; Casali, PG; Wunder, JS; Gronchi, A Development and external validation of a dynamic prognostic nomogram for primary extremity soft tissue sarcoma survivors.
EClinicalMedicine. 2019; 17: 100215-100215. Doi: 10.1016/j.eclinm.2019.11.008 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Dieckmann, KP; Radtke, A; Geczi, L; Matthies, C; Anheuser, P; Eckardt, U; Sommer, J; Zengerling, F; Trenti, E; Pichler, R; Belz, H; Zastrow, S; Winter, A; Melchior, S; Hammel, J; Kranz, J; Bolten, M; Krege, S; Haben, B; Loidl, W; Ruf, CG; Heinzelbecker, J; Heidenreich, A; Cremers, JF; Oing, C; Hermanns, T; Fankhauser, CD; Gillessen, S; Reichegger, H; Cathomas, R; Pichler, M; Hentrich, M; Eredics, K; Lorch, A; Wülfing, C; Peine, S; Wosniok, W; Bokemeyer, C; Belge, G Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
J Clin Oncol. 2019; 37(16): 1412-1423. Doi: 10.1200/JCO.18.01480 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Filipits, M; Dubsky, P; Rudas, M; Greil, R; Balic, M; Bago-Horvath, Z; Singer, CF; Hlauschek, D; Brown, K; Bernhisel, R; Kronenwett, R; Lancaster, JM; Fitzal, F; Gnant, M Prediction of Distant Recurrence Using EndoPredict Among Women with ER+, HER2- Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy Only.
Clin Cancer Res. 2019; 25(13):3865-3872 Doi: 10.1158/1078-0432.CCR-19-0376 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Fitzal, F; Bjelic-Radisic, V; Knauer, M; Steger, G; Hubalek, M; Balic, M; Singer, C; Bartsch, R; Schrenk, P; Soelkner, L; Greil, R; Gnant, M Impact of Breast Surgery in Primary Metastasized Breast Cancer Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE Trial
ANN SURG. 2019; 269(6): 1163-1169. Doi: 10.1097/SLA.0000000000002771
Web of Science PubMed FullText FullText_MUG

 

** Gebhart, J; Posch, F; Koder, S; Quehenberger, P; Perkmann, T; Kuessel, L; Ay, C; Pabinger, I High risk of adverse pregnancy outcomes in women with a persistent lupus anticoagulant.
Blood Adv. 2019; 3(5): 769-776. Doi: 10.1182/bloodadvances.2018026948 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Gnant, M; Pfeiler, G; Steger, GG; Egle, D; Greil, R; Fitzal, F; Wette, V; Balic, M; Haslbauer, F; Melbinger-Zeinitzer, E; Bjelic-Radisic, V; Jakesz, R; Marth, C; Sevelda, P; Mlineritsch, B; Exner, R; Fesl, C; Frantal, S; Singer, CF, , Austrian, Breast, and, Colorectal, Cancer, Study, Group Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol. 2019; 20(3):339-351 Doi: 10.1016/S1470-2045(18)30862-3
Web of Science PubMed FullText FullText_MUG

 

** Goldzweig, G; Schapira, L; Baider, L; Jacobs, JM; Andritsch, E; Rottenberg, Y Who will care for the caregiver? Distress and depression among spousal caregivers of older patients undergoing treatment for cancer.
Support Care Cancer. 2019; 27(11):4221-4227 Doi: 10.1007/s00520-019-04711-6
Web of Science PubMed FullText FullText_MUG

 

** Grilz, E; Marosi, C; Königsbrügge, O; Riedl, J; Posch, F; Lamm, W; Lang, IM; Pabinger, I; Ay, C Association of complete blood count parameters, d-dimer, and soluble P-selectin with risk of arterial thromboembolism in patients with cancer.
J Thromb Haemost. 2019; 17(8): 1335-1344. Doi: 10.1111/jth.14484 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Grilz, E; Mauracher, LM; Posch, F; Königsbrügge, O; Zöchbauer-Müller, S; Marosi, C; Lang, I; Pabinger, I; Ay, C Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancer.
Br J Haematol. 2019; 186(2): 311-320. Doi: 10.1111/bjh.15906 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hell, L; Ay, C; Posch, F; Gebhart, J; Koder, S; Mackman, N; Pabinger, I; Thaler, J Low extracellular vesicle-associated tissue factor activity in patients with persistent lupus anticoagulant and a history of thrombosis.
Ann Hematol. 2019; 98(2):313-319 Doi: 10.1007/s00277-018-3544-x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hutterer, GC; Pichler, M Advanced/metastatic urothelial carcinoma of the bladder and upper urinary tract Presentation highlights from the ASCO 2019 Congress
MEMO-MAG EUR MED ONC. 2019; Doi: 10.1007/s12254-019-00532-9
Web of Science FullText FullText_MUG

 

** Hutterer, GC; Posch, F; Buser, L; Zigeuner, R; Morshäuser, L; Otto, W; Wild, PJ; Burger, M; May, M; Pichler, M; Brookman-May, SD BioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation study.
Urol Oncol. 2019; 37(7): 510-518. Doi: 10.1016/j.urolonc.2019.04.004
Web of Science PubMed FullText FullText_MUG

 

** Čipak Gašparović, A; Milković, L; Dandachi, N; Stanzer, S; Pezdirc, I; Vrančić, J; Šitić, S; Suppan, C; Balic, M Chronic Oxidative Stress Promotes Molecular Changes Associated with Epithelial Mesenchymal Transition, NRF2, and Breast Cancer Stem Cell Phenotype.
Antioxidants (Basel). 2019; 8(12): 633 Doi: 10.3390/antiox8120633 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Klec, C; Gutschner, T; Panzitt, K; Pichler, M Involvement of long non-coding RNA HULC (highly up-regulated in liver cancer) in pathogenesis and implications for therapeutic intervention.
Expert Opin Ther Targets. 2019; 23(3): 177-186. Doi: 10.1080/14728222.2019.1570499
Web of Science PubMed FullText FullText_MUG

 

** Klec, C; Madreiter-Sokolowski, CT; Ziomek, G; Stryeck, S; Sachdev, V; Duta-Mare, M; Gottschalk, B; Depaoli, MR; Rost, R; Hay, J; Waldeck-Weiermair, M; Kratky, D; Madl, T; Malli, R; Graier, WF Presenilin-1 Established ER-Ca2+ Leak: a Follow Up on Its Importance for the Initial Insulin Secretion in Pancreatic Islets and β-Cells upon Elevated Glucose.
Cell Physiol Biochem. 2019; 53(3): 573-586. Doi: 10.33594/000000158 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

** Klec, C; Prinz, F; Pichler, M Involvement of the long noncoding RNA NEAT1 in carcinogenesis.
Mol Oncol. 2019; 13(1):46-60 Doi: 10.1002/1878-0261.12404 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Klec, C; Ziomek, G; Pichler, M; Malli, R; Graier, WF Calcium Signaling in ß-cell Physiology and Pathology: A Revisit.
Int J Mol Sci. 2019; 20(24): Doi: 10.3390/ijms20246110 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Lembeck, AL; Posch, F; Klocker, EV; Szkandera, J; Schlick, K; Stojakovic, T; Kornprat, P; Lackner, C; Gerger, A; Stoeger, H; Stotz, M; Pichler, M Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancer.
Clin Chem Lab Med. 2019; 57(5):740-744 Doi: 10.1515/cclm-2018-0016
Web of Science PubMed FullText FullText_MUG

 

** Madreiter-Sokolowski, CT; Waldeck-Weiermair, M; Bourguignon, MP; Villeneuve, N; Gottschalk, B; Klec, C; Stryeck, S; Radulovic, S; Parichatikanond, W; Frank, S; Madl, T; Malli, R; Graier, WF Enhanced inter-compartmental Ca2+ flux modulates mitochondrial metabolism and apoptotic threshold during aging.
Redox Biol. 2019; 20:458-466 Doi: 10.1016/j.redox.2018.11.003 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Mayr, C; Beyreis, M; Dobias, H; Gaisberger, M; Fuchs, J; Pichler, M; Ritter, M; Jakab, M; Helm, K; Neureiter, D; Kiesslich, T Continuous, label-free, 96-well-based determination of cell migration using confluence measurement.
Cell Adh Migr. 2019; 13(1):76-82 Doi: 10.1080/19336918.2018.1526612 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Moik, F; Riedl, JM; Winder, T; Terbuch, A; Rossmann, CH; Szkandera, J; Bauernhofer, T; Kasparek, AK; Schaberl-Moser, R; Reicher, A; Prinz, F; Pichler, M; Stöger, H; Stotz, M; Gerger, A; Posch, F Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis.
Sci Rep. 2019; 9(1):5548 Doi: 10.1038/s41598-019-42069-1 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Müller, HD; Posch, F; Suppan, C; Bargfrieder, U; Gumpoldsberger, M; Hammer, R; Hauser, H; Dandachi, N; Prein, K; Stoeger, H; Lax, S; Balic, M Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy.
Ann Surg Oncol. 2019; 26(13):4274-4283 Doi: 10.1245/s10434-019-07741-w [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Pichler, R; Compérat, E; Klatte, T; Pichler, M; Loidl, W; Lusuardi, L; Schmidinger, M Renal Cell Carcinoma with Sarcomatoid Features: Finally New Therapeutic Hope?
Cancers (Basel). 2019; 11(3): 422 Doi: 10.3390/cancers11030422 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Posch, F; Ay, C; Stöger, H; Kreutz, R; Beyer-Westendorf, J Exposure to vitamin k antagonists and kidney function decline in patients with atrial fibrillation and chronic kidney disease.
Res Pract Thromb Haemost. 2019; 3(2): 207-216. Doi: 10.1002/rth2.12189 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Posch, F; Ay, C; Stöger, H; Kreutz, R; Beyer-Westendorf, J Longitudinal kidney function trajectories predict major bleeding, hospitalization and death in patients with atrial fibrillation and chronic kidney disease.
Int J Cardiol. 2019; 282: 47-52. Doi: 10.1016/j.ijcard.2019.01.089
Web of Science PubMed FullText FullText_MUG

 

** Prinz, F; Kapeller, A; Pichler, M; Klec, C The Implications of the Long Non-Coding RNA NEAT1 in Non-Cancerous Diseases.
Int J Mol Sci. 2019; 20(3): Doi: 10.3390/ijms20030627 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Richtig, G; Aigelsreiter, AM; Asslaber, M; Weiland, T; Pichler, M; Eberhard, K; Sygulla, S; Schauer, S; Hoefler, G; Aigelsreiter, A Hedgehog pathway proteins SMO and GLI expression as prognostic markers in head and neck squamous cell carcinoma.
Histopathology. 2019; 75(1):118-127 Doi: 10.1111/his.13860 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Richtig, G; Ramelyte, E; Koch, L; Greinix, H; Ferrone, S; Dummer, R; Richtig, E Unmasking of a primary desmoplastic melanoma tumour in the course of treatment of a metastatic disease with anti-PD-1 monoclonal antibody.
J Eur Acad Dermatol Venereol. 2019; 33(10):e381-e383-e381-e383 Doi: 10.1111/jdv.15675 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Richtig, G; Richtig, E; Böhm, A; Oing, C; Bozorgmehr, F; Kruger, S; Kiesewetter, B; Zielinski, C; Berghoff, AS Awareness of predatory journals and open access among medical oncologists: results of an online survey.
ESMO Open. 2019; 4(6): e000580-e000580. Doi: 10.1136/esmoopen-2019-000580 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Riedl, JM; Stotz, M; Gerger, A Role of immune checkpoint inhibitors in gastrointestinal cancer treatment
MEMO-MAG EUR MED ONC. 2019; 12(1): 71-76. Doi: 10.1007/s12254-019-0470-0 [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Scheipl, S; Liegl-Atzwanger, B; Szkandera, J; Rinner, B; Viertler, C; Friesenbichler, J; Bergovec, M; Leithner, A [Is there a magic bullet for sarcomas? : Personalised treatment for maligant tumours of bone and soft tissue].
Orthopade. 2019; 48(9): 776-783. Doi: 10.1007/s00132-019-03790-x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Scheithauer, W; Putora, PM; Grünberger, B; Eisterer, W; Wöll, E; Prager, G; Schaberl-Moser, R; Greil, R; Glatzer, M Patterns of care in metastatic pancreatic cancer: patient selection in clinical routine.
Therap Adv Gastroenterol. 2019; 12(5):1756284819877635-1756284819877635 Doi: 10.1177/1756284819877635 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Schlick, K; Magnes, T; Huemer, F; Ratzinger, L; Weiss, L; Pichler, M; Melchardt, T; Greil, R; Egle, A C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling overall survival Prediction in Pancreatic Cancer Patients.
J Clin Med. 2019; 8(11): Doi: 10.3390/jcm8111791 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Schmidinger, M; Pichler, R; Loidl, W; Bauernhofer, T; Kretz, M; Tinchon, C; Niedersüß-Beke, D; Pfleger, G; Wiesinger, CG; Vogl, U; Mitterberger, M; Stöger, H; Tulchiner, G; Kratochvill, F; Gerritsmann, H; Mraz, B; Marszalek, M Real-World Evidence Data on Metastatic Renal-Cell Carcinoma Treatment in Austria: The RELACS Study.
Clin Genitourin Cancer. 2019; 17(5):e957-e967-e957-e967 Doi: 10.1016/j.clgc.2019.05.017 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schratter, G; Scheruebel, S; Langthaler, S; Ester, K; Pelzmann, B; Ghaffari-Tabrizi-Wizsy, N; Rezania, S; Gorischek, A; Platzer, D; Zorn-Pauly, K; Ahammer, H; Prokesch, A; Stanzer, S; Devaney, TTJ; Schmidt, K; Jahn, SW; Prassl, R; Bauernhofer, T; Schreibmayer, W; GIRK1 triggers multiple cancer-related pathways in the benign mammary epithelial cell line MCF10A.
SCI REP. 2019; 9: 19277 Doi: 10.1038/s41598-019-55683-w [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Schwarzenbacher, D; Klec, C; Pasculli, B; Cerk, S; Rinner, B; Karbiener, M; Ivan, C; Barbano, R; Ling, H; Wulf-Goldenberg, A; Stanzer, S; Rinnerthaler, G; Stoeger, H; Bauernhofer, T; Haybaeck, J; Hoefler, G; Jahn, SW; Parrella, P; Calin, GA; Pichler, M MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors.
Breast Cancer Res. 2019; 21(1): 20-20. Doi: 10.1186/s13058-019-1104-5 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Singer, CF; Filipits, M; Jahn, SW; Abete, L; Jakesz, R; Greil, R; Bauernhofer, T; Kwasny, W; Seifert, M; Fitzal, F; Kastner, M; Schmitt, M; Moinfar, F; Gnant, M Stromal coexpression of uPA/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer.
Breast. 2019; 46(14):101-107 Doi: 10.1016/j.breast.2019.05.007 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Smolle, E; Fink-Neuboeck, N; Lindenmann, J; Smolle-Juettner, F; Pichler, M The Biological and Clinical Relevance of Inhibitor of Growth (ING) Genes in Non-Small Cell Lung Cancer.
Cancers (Basel). 2019; 11(8): Doi: 10.3390/cancers11081118 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smolle, MA; Kashofer, K; Riedl, JM; Stotz, M; Gerger, A Genetic Analysis Using a Gene Panel in 87 Caucasian Patients With Colorectal Cancer: Own Results and Review of Literature.
Anticancer Res. 2019; 39(2): 847-852. Doi: 10.21873/anticanres.13184
Web of Science PubMed FullText FullText_MUG

 

** Smolle, MA; Prinz, F; Calin, GA; Pichler, M Current concepts of non-coding RNA regulation of immune checkpoints in cancer.
Mol Aspects Med. 2019; 70:117-126 Doi: 10.1016/j.mam.2019.09.007
Web of Science PubMed FullText FullText_MUG

 

** Smolle, MA; van Praag, VM; Posch, F; Bergovec, M; Leitner, L; Friesenbichler, J; Heregger, R; Riedl, JM; Pichler, M; Gerger, A; Szkandera, J; Stöger, H; Smolle-Jüttner, FM; Liegl-Atzwanger, B; Fiocco, M; van de Sande, MA; Leithner, A Surgery for metachronous metastasis of soft tissue sarcoma - A magnitude of benefit analysis using propensity score methods.
Eur J Surg Oncol. 2019; 45(2):242-248 Doi: 10.1016/j.ejso.2018.06.019
Web of Science PubMed FullText FullText_MUG

 

** Suppan, C; Balic, M Adjuvant breast cancer: (neo)adjuvant therapy for HER2-positive breast cancer The best of ASCO 2019
MEMO-MAG EUR MED ONC. 2019; Doi: 10.1007/s12254-019-00530-x [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Suppan, C; Brcic, I; Tiran, V; Mueller, HD; Posch, F; Auer, M; Ercan, E; Ulz, P; Cote, RJ; Datar, RH; Dandachi, N; Heitzer, E; Balic, M Untargeted Assessment of Tumor Fractions in Plasma for Monitoring and Prognostication from Metastatic Breast Cancer Patients Undergoing Systemic Treatment.
Cancers (Basel). 2019; 11(8): Doi: 10.3390/cancers11081171 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Terbuch, A; Posch, F; Bauernhofer, T; Pichler, M; Peinsith, H; Szkandera, J; Riedl, J; Hutterer, GC; Pummer, K; Partl, R; Kapp, KS; Stöger, H; Stotz, M; Gerger, A Age as a Predictor of Treatment Outcome in Metastatic Testicular Germ Cell Tumors.
Anticancer Res. 2019; 39(10):5589-5596 Doi: 10.21873/anticanres.13753
Web of Science PubMed FullText FullText_MUG

 

** Ulz, P; Perakis, S; Zhou, Q; Moser, T; Belic, J; Lazzeri, I; Wölfler, A; Zebisch, A; Gerger, A; Pristauz, G; Petru, E; White, B; Roberts, CES; John, JS; Schimek, MG; Geigl, JB; Bauernhofer, T; Sill, H; Bock, C; Heitzer, E; Speicher, MR Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection.
Nat Commun. 2019; 10(1): 4666-4666. Doi: 10.1038/s41467-019-12714-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Vehabovic-Delic, A; Balic, M; Rossmann, C; Bauernhofer, T; Deutschmann, HA; Schoellnast, H Volume Computed Tomography Perfusion Imaging: Evaluation of the Significance in Oncologic Follow-up of Metastasizing Renal Cell Carcinoma in the Early Period of Targeted Therapy - Preliminary Results.
J Comput Assist Tomogr. 2019; 43(3):493-498 Doi: 10.1097/RCT.0000000000000848
Web of Science PubMed FullText FullText_MUG

 

** Waldeck-Weiermair, M; Gottschalk, B; Madreiter-Sokolowski, CT; Ramadani-Muja, J; Ziomek, G; Klec, C; Burgstaller, S; Bischof, H; Depaoli, MR; Eroglu, E; Malli, R; Graier, WF Development and Application of Sub-Mitochondrial Targeted Ca2 + Biosensors.
Front Cell Neurosci. 2019; 13: 449-449. Doi: 10.3389/fncel.2019.00449 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Wöll, E; Eisterer, W; Gerger, A; Kühr, T; Prager, GW; Rumpold, H; Ulrich-Pur, H; Vogl, U; Winder, T; Weiss, L; Greil, R Treatment Algorithm for Patients With Gastric Adenocarcinoma: An Austrian Consensus on Systemic Therapy.
Anticancer Res. 2019; 39(9): 4589-4596. Doi: 10.21873/anticanres.13638 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Xiao, H; Shiu, PKT; Gabryleska, M; Conn, SJ; Dey, A; Chakrabarti, K; Regouc, M; Pichler, M; Ørom, UAV; Santulli, G; Nishiwada, S; Goel, A; Nagarajan, V; Timmons, L; Alahari, SK; Laprovitera, N; Ferracin, M; Hu, P; Jin, H The Non-Coding RNA Journal Club: Highlights on Recent Papers-7.
Noncoding RNA. 2019; 5(2): 40 Doi: 10.3390/ncrna5020040 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

** Aziz, F; Stelzl, A; Riedl, J; Smolle, M; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stoger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Szkandera, J; Sourij, H Diabetes is a predictor for survival in soft tissue sarcoma patients
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S477-S477. [Poster]
Web of Science

 

** Aziz, F; Stelzl, A; Riedl, JM; Smolle, MA; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stoger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Szkandera, J; Sourij, H Association of serum glucose levels with disease free survival in soft tissue sarcoma patients
DIABETOLOGIA. 2019; 62: S562-S563.-55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 16-20, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

** Balic, M; Suppan, C; Brcic, I; Tiran, V; Mueller, DH; Posch, F; Ulz, P; Heitzer, E; Dandachi, N Untargeted assessment of tumour fractions in plasma for monitoring and prognostication from metastatic breast cancer patients undergoing systemic treatment
ANN ONCOL. 2019; 30: 110-+.-44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

** Barth, DA; Riedl, JM; Foris, V; Posch, F; Mollnar, S; Stotz, M; Pichler, M; Stoger, H; Absenger, G; Olschewski, H; Gerger, A External validation and longitudinal extension of the LIPI (lung immune prognostic index) for immunotherapy outcomes in advanced non-small cell lung cancer
ONCOL RES TREAT. 2019; 42: 108-108. [Poster]
Web of Science

 

** Coronel, DSP; Guglielmetti, DM; Posch, F; Ay, C; Aramberri, M; Zambrano, MDCB; Font, C Performance of the '4S rule' to predict short-term outcomes in cancer outpatients with unsuspected pulmonary embolism
ANN ONCOL. 2019; 30: -44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

** Dandachi, N; Absenger, G; Brcic, L; Kashofer, K; Terbuch, A; Jaritz, L; Stanzer, S; Balic, M Feasibility and clinical value of serial circulating tumor DNA testing in metastatic lung adenocarcinoma patients undergoing TKI treatment
ONCOL RES TREAT. 2019; 42: 213-213. [Poster]
Web of Science

 

** Dandachi, N; Suppan, C; Brcic, L; Tiran, V; Mueller, DH; Posch, F; Ulz, P; Heitzer, E; Balic, M Monitoring therapy response and assessing prognosis by untargeted FAST-SeqS of circulating tumor DNA in metastatic breast cancer patients
ONCOL RES TREAT. 2019; 42: 41-41. [Poster]
Web of Science

 

** Devyatko, Y; Filipits, M; Greil, R; Balic, M; Bago-Horvath, Z; Singer, C; Fitzal, F; Steger, G; Gray, B; Ferree, S; Fesl, C; Soelkner, L; von Minckwitz, G; Gnant, M The impact of clinical risk assessment versus PAM-50 ROR score on prognosis and therapeutic decision making in patients with hormone-receptor positive early stage breast cancer
CANCER RES. 2019; 79(4): Doi: 10.1158/1538-7445.SABCS18-P1-17-05 [Poster]
Web of Science FullText FullText_MUG

 

** Donsa, K; Stampfer, P; Truskaller, T; Kopanz, J; Konig, C; Lichtenegger, K; Mrak, P; Pinter, G; Schippinger, W; Sinner, F Development of an innovative eHealth System for comprehensive Quality Assurance and Therapy Support in Austrian Institutions of Acute Geriatrics and Remobilization - Presentation of a user-centered Development Process
Z GERONTOL GERIATR. 2019; 52: S158-S158. [Poster]
Web of Science

 

** Fastner, G; Sedlmayer, F; Widder, J; Metz, M; Geinitz, H; Kapp, K; Solkner, L; Greil, R; Jakesz, R; Kwasny, W; Heck, D; Bjelic-Radisic, V; Balic, M; Stoger, H; Wieder, U; Zwrtek, R; Semmler, D; Horvath, W; Melbinger-Zeinitzer, E; Wiesholzer, M; Wette, V; Gnant, M Antihormones with or without irradiation in breast cancer: 10-year results of the ABCSG 8A trial
RADIOTHER ONCOL. 2019; 133: S132-S133.-38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO); APR 26-30, 2019; Milan, ITALY. Doi: 10.1016/S0167-8140(19)30690-5 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Fediuk, M; Fink-Neubock, N; Maier, A; Lindenmann, J; Balic, M; Smolle-Juttner, FM Bronchial Cancer - personalized
WIEN KLIN WOCHENSCHR. 2019; 131(19-20):508-508. [Oral Communication]
Web of Science

 

** Filipits, M; Dubsky, P; Rudas, M; Greil, R; Balic, M; Fitzal, F; Bago-Horvath, Z; Singer, C; Hlauschek, D; Kronenwett, R; Bernhisel, R; Lancaster, J; Gnant, M Prediction of distant recurrence using EndoPredict among women with ER-positive, HER2-negative breast cancer with a maximum follow-up of 16 years
CANCER RES. 2019; 79(4):-San Antonio Breast Cancer Symposium; DEC 04-08, 2018; San Antonio, TX. Doi: 10.1158/1538-7445.SABCS18-P4-08-05 [Poster]
Web of Science FullText FullText_MUG

 

** Fischer, SC; Tandstad, T; Cohn-Cedermark, GE; Thibault, C; Vincenzi, B; Klingbiel, D; Albany, C; Necchi, A; Terbuch, A; Lorch, A; Aparicio, J; Heidenreich, A; Hentrich, M; Wheater, MJ; Langberg, CW; Stahl, O; Beyer, J; Gillessen, S Outcome of men with relapses after adjuvant BEP for clinical stage I nonseminoma.
J CLIN ONCOL. 2019; 37(7):-ASCO-GU Genitourinary Cancers Symposium; FEB 15, 2019; San Francisco, CA. Doi: 10.1200/JCO.2019.37.7_suppl.510 [Oral Communication]
Web of Science FullText FullText_MUG

 

** Gampenrieder, SPP; Rinnerthaler, G; Petzer, A; Tinchon, C; Fuchs, D; Balic, M; Heibl, S; Rumpold, H; Egle, D; Zabernigg, AF; Singer, CF; Andel, J; Hubalek, M; Knauer, M; Greil, R Impact of pertuzumab and T-DM1 on prognosis of HER2-positive metastatic breast cancer (MBC) and factors affecting their efficacy: Results from the AGMT_MBC-registry
ANN ONCOL. 2019; 30: 126-+.-44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

** Glantschnig, T; Posch, F; Firla, S; Moik, F; Ablasser, K; Binder, JS; Stoschitzky, G; Wallner, M; Von Lewinski, D; Stoger, H; Zirlik, A; Pichler, M; Rainer, PP Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+early breast cancer undergoing trastuzumab-based therapy
WIEN KLIN WOCHENSCHR. 2019; 131: 292-293. [Poster]
Web of Science

 

** Glaser, JM; Rainer, F; Streit, A; Posch, A; Lipp, RW; Kump, P Incidence of Secondary Malignoma in Patients with Gastro-Enteropancreatic Neuroendocrine Neoplasia
NEUROENDOCRINOLOGY. 2019; 108: 62-62. [Poster]
Web of Science

 

** Guglielmetti, DM; Pesantez, D; Posch, F; Ay, C; Aramberri, M; Zambrano, MDCB; Diaz-Pedroche, C; Font, C Short-term outcomes of cancer patients with pulmonary embolism according to the setting (hospital-acquired vs. outpatient) at diagnosis
ANN ONCOL. 2019; 30: -44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

** Hochmair, MJ; Weinlinger, C; Fabikan, H; Illini, O; Krenbek, D; Setinek, U; Watzka, S; Koger, R; Meilinger, M; Absenger, G; Wanke, M; Semmelweis, C; Rauter, M; Valipour, A Treatment Observations and Clinical Experience with Lorlatinib in Pretreated ALK and ROS1 Rearranged NSCLC Patients
J THORAC ONCOL. 2019; 14(10):S847-S847. Doi: 10.1016/j.jtho.2019.08.1831 [Poster]
Web of Science FullText FullText_MUG

 

** Kocher, F; Seeber, A; Weiss, L; Romeder, F; Szkandera, J; Kuhr, T; Kostner, S; Pichler, P; Jager, T; Greil, R; Brodowicz, T Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma: Data of real-world utilization in Austria.
J CLIN ONCOL. 2019; 37(15):-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); MAY 31-JUN 04, 2019; Chicago, IL. [Poster]
Web of Science

 

** Krstic, J; Reinisch, I; Depaoli, M; Berger, N; Noessing, C; Galhuber, M; Anders, I; Auer, M; Moyschewitz, E; Rinner, B; Pichler, M; Malli, R; Prokesch, A Overcoming sorafenib resistance in hepatocellular carcinoma by fasting
BRIT J CANCER. 2019; 121: 16-17. [Oral Communication]
Web of Science FullText

 

** Libiseller, A; Lichtenegger, KM; Kopanz, J; De Campo, A; Wiesinger, T; Weidinger, L; Laubreiter, L; Schippinger, W; Truskaller, T; Lackner, BC; Beck, P; Holl, B; Pieber, TR Improving Glycemic Management of Patients with Type 2 Diabetes in Acute Geriatric Care by Using a Basal Insulin Algorithm Incorporated into a Workflow and Decision Support System
DIABETES. Diabetes 2019 Jun; 68(Supplement 1): -. . 2019; 68: -79th Scientific Sessions of the American-Diabetes-Association (ADA); JUN 07-11, 2019; San Francisco, CA. Doi: 10.2337/db19-952-P [Poster]
Web of Science FullText FullText_MUG

 

** Perakis, SO; Ulz, P; Riedl, JM; Scheipner, L; Kashofer, K; Hoefler, G; Geigl, JB; Speicher, MR; Heitzer, E; Gerger, A Molecular-biological tumor profiling for drug treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage Phase II individualized cancer treatment study
CANCER RES. 2019; 79(13):-Annual Meeting of the American-Association-for-Cancer-Research (AACR); MAR 29-APR 03, 2019; Atlanta, GA. Doi: 10.1158/1538-7445.AM2019-CT130 [Poster]
Web of Science FullText FullText_MUG

 

** Posch, F; Glantschnig, T; Firla, S; Smolle, M; Balic, M; Moik, F; Stoeger, H; Zirlik, A; Pichler, M; Rainer, P Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+early breast cancer undergoing trastuzumab-based therapy
EUR HEART J. 2019; 40: 3844-3844.-ESC Congress / World Congress of Cardiology; AUG 31-SEP 04, 2019; Paris, FRANCE. [Poster]
Web of Science

 

** Riedl, J; Posch, F; Prager, G; Eisterer, W; Ohler, L; Thamer, S; Wilthoner, K; Petzer, A; Pichler, P; Hubmann, E; Winder, T; Burgstaller, S; Korger, M; Andel, J; Greil, R; Pecherstorfer, M; Philipp-Abbrederis, K; Djanani, A; Gruenberger, B; Langle, F; Woll, E; Gerger, A The AST/ALT (De Ritis) ratio predicts clinical outcome in pancreatic cancer patients treated with first-line nab-paclitaxel and gemcitabine: post-hoc analysis of an Austrian multicenter, non-interventional study
ANN ONCOL. 2019; 30: -European-Society-for-Medical-Oncology (ESMO) 21st World Congress on Gastrointestinal Cancer; JUL 03-06, 2019; Barcelona, SPAIN. Doi: 10.1093/annonc/mdz155.285 [Poster] [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Riedl, JM; Barth, D; Posch, F; Foris, V; Absenger, G; Mollnar, S; Pichler, M; Stotz, M; Stoger, H; Olschewski, H; Gerger, A Longitudinal C-reactive protein (CRP) trajectories predict immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer
ONCOL RES TREAT. 2019; 42: 115-115. [Poster]
Web of Science

 

** Riedl, JM; Barth, DA; Foris, V; Posch, F; Mollnar, S; Stotz, M; Pichler, M; Stoger, H; Absenger, G; Olschewski, H; Gerger, A External validation and longitudinal extension of the LIPI (Lung Immune Prognostic Index) for immunotherapy outcomes in advanced non-small cell lung cancer
ANN ONCOL. 2019; 30: -44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

** Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Burgstaller, S; Voskova, D; Rossmann, D; Balic, M; Egle, D; Rumpold, H; Singer, CF; Petru, E; Melchardt, T; Ulmer, H; Mlineritsch, B; Greil, R Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, an ongoing phase I/II trial (AGMT MBC-10 trial)
CANCER RES. 2019; 79(4):-San Antonio Breast Cancer Symposium; DEC 04-08, 2018; San Antonio, TX. Doi: 10.1158/1538-7445.SABCS18-OT3-07-01 [Poster]
Web of Science FullText FullText_MUG

 

** Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Tinchon, C; Fuchs, D; Balic, M; Heibl, S; Rumpold, H; Egle, D; Zabernigg, AF; Singer, CF; Andel, J; Hubalek, M; Knauer, M; Greil, R First data on overall survival of metastatic breast cancer patients in Austria according to breast cancer subtype: results from the AGMT MBC Registry
ONCOL RES TREAT. 2019; 42: 40-40.
Web of Science

 

** Singer, CF; Oehler, L; Egle, D; Greil, R; Petru, E; Balic, M; Marhold, M; Pfeiler, G; Brunner, C; Kwasny, W; Galid, AA; Tinchon, C; Eisterer, W; Haslbauer, F; Hubalek, M; Redl, A; Hock, K; Hennebelle, M; Mraz, B; Steger, GG REACHAUT: First-line (1L) ribociclib (RIB) plus endocrine therapy (ET) in HR+, HER2-metastatic breast cancer (MBC) in the real-world setting.
J CLIN ONCOL. 2019; 37(15):-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); MAY 31-JUN 04, 2019; Chicago, IL. Doi: 10.1200/JCO.2019.37.15_suppl.e12527 [Poster]
Web of Science FullText FullText_MUG

 

** Steger, G; Galid, A; Rechberger, E; Eisterer, W; Herz, W; Petru, E; Pasterk, C; Girschikofsky, M; Singer, C; Grunberger, B; Stoger, H; Marhold, M; Hitzl, D; Lindegger, N Exploring real world data treatment patterns and outcomes in participants with HER2+unresectable LA/mBC - Austrian participation in the prospective European registry SAMANTHA study
ONCOL RES TREAT. 2019; 42: 41-42.
Web of Science

 

** Szkandera, J Which therapies for which molecular subtypes?
ONCOL RES TREAT. 2019; 42: 239-240.
Web of Science

 

** Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Niedersuss-Beke, D; Tinchon, C; Loidl, W; Pichler, M; Jahn, S; Stoger, H; Bauernhofer, T; Lymphopenia impairs response to 1st-line tyrosine kinase inhibitor therapy in patients with metastatic clear-cell renal cell carcinoma and modulates the relative efficacy of sunitinib and pazopanib
WIEN KLIN WOCHENSCHR. 2019; 131: S447-S447.-Frühjahrstagung der OeGHO; APR 11-13, 2019; Linz, AUSTRIA. [Poster]
Web of Science FullText

 

** Terzic, J; Tinchon, C; Stoger, H Smoker's Cough - what's behind it?
WIEN KLIN WOCHENSCHR. 2019; 131: S434-S435. [Oral Communication]
Web of Science

 

Angelika Terbuch, Irene Moreno Candilejo, Mariana Scaranti, Daniel Bar, Miriam Estevez Timon, Malaka Ameratunga, Joo Ern Ang, Jonathan Ratoff, Anna Minchom, Udai Banerji, Johann S. De Bono, Nina Tunariu, Juanita Suzanne Lopez Distinct radiological patterns of drug-induced pneumonitis (R-DIP) in early-phase clinical trials and predictive factors affecting outcome: A 10-year systematic review from the Royal Marsden Hospital Phase I Drug Development Unit experience
Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019) 3088-3088. 2019; -Annual Metting of the American Society for Clinical Oncology; June 1, 2019; Chicago. [Poster]

 

Barth, D; Riedl, JM; Posch, F; Smolle, MA; Kasparek, AK; Niedrist, T; Szkandera, J; Stöger, H; Pichler, M; Gerger, A; Stotz, M Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study.
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. 2019; -OeGHO Frühjahrstagung 2019; APR 11-13; Linz, AUSTRIA. [Poster]

 

Borzan, V; Gumpold, R; Stiegelbauer, V; Frauwallner, A; Obermayer-Pietsch, B; ProPCO Pilot Studie – Probiotische Interventionsstudie zur Behandlung des Polyzystischen Ovarsydroms.
http://www.oeges.at/wp/wp-content/uploads/02_hauptprogramm_web.pdf. 2019; -ÖGES 2019; APR 24-26, 2019; Graz, AUSTRIA. [Poster]

 

Jasmin Terzic*1, Christoph Tinchon2, Herbert Stöger1 Raucherhusten was steckt dahinter?
50. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin. Wien Klin Wochenschr 131. 2019; 429-457.-ÖGIM Jahrestagung; Sep 19-21,2019; Salzburg. [Oral Communication]
FullText

 

Johann S. De Bono, David Shao Peng Tan, Reece Caldwell, Angelika Terbuch, Boon C. Goh, Valerie Heong, Noor Md Haris, Saira Bashir, David S. Hong, Funda Meric-Bernstam, Sonal Bordia, LI Liu, Gary Wilkinson, Joseph Hreiki, Antje Wengner, Kerstin Fischer, Oliver Boix, Eleni Lagkadinou, Elizabeth Plummer, Timothy A Yap First-in-human trial of the oral ataxia telangiectasia and Rad3-related (ATR) inhibitor BAY 1895344 in patients (pts) with advanced solid tumors
Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019) 3007-3007. 2019; -Annual Meeting of thre American Society of Clinical Oncology 2019; June 3, 2019; Chicago. [Oral Communication]

 

Jonas, K; Herbst, R Serine Phosphorylation as a Novel Regulatory Mechanism in Muscle Specific Kinase Signaling
15th YSA PhD Symposium, Medical University of Vienna. 2019; -Young Scientist Association (YSA) PhD Symposium; June 13-14, 2019; Vienna, Austria. [Poster]

 

Jonas, K; Herbst, R A Potential Role of CaMKIIβ in the Regulation of Muscle Specific Kinase Signaling.
Doctoral Day of the Medical University of Graz. 2019; -Doctoral Day of the Medical University of Graz; NOV 21, 2019; Graz, AUSTRIA. [Poster]

 

Klec, C; Kapeller, A; Prinz, F; Trenk, C; Stoeger, H; Pichler, M Dissecting the interplay of the long non-coding RNA NORAD and PARP inhibitors in triple negative breast cancer.
San Antonio Breast Cancer Symposium. 2019; -SABCS; DEC 10-14; San Antonio, TX, USA. [Poster]

 

Klec, C; Schwarzenbacher, D; Gottschalk, B; Resel, M; Prinz, F; Heitzer, E; Bauernhofer, T; Stöger, H; Graier, WF; Pichler, M Paraspeckle-associated protein 1 (PAP1) controls breast cancer growth by regulating and interacting with the long non-coding RNA NEAT1
ÖGHO Frühjahrstagung 2019. 2019; -ÖGHO Frühjahrstagung 2019; 11.-13.April; Linz, AUSTRIA. [Poster]

 

Klec, C; Schwarzenbacher, D; Resel, M; Rinner, B; Haybaeck, J; Höfler, G; Jahn, SW; Bauernhofer, T; Stöger, H; Pichler, M miR-1287-5p inhibits triple negative breast cancer growth by interacting with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors
ÖGHO Frühjahrstagung 2019. 2019; -ÖGHO Frühjahrstagung 2019; 11.-13.April; Linz, AUSTRIA. [Oral Communication]

 

Klec, C; Schwarzenbacher, D; Resel, M; Rinner, B; Haybaeck, J; Höfler, G; Jahn, SW; Bauernhofer, T; Stöger, H; Pichler, M miR-1287-5p inhibits triple negative breast cancer growth by interacting with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors
ÖGHO Frühjahrstagung 2019. 2019; -ÖGHO Frühjahrstagung; 11.-13.April; Linz, AUSTRIA. [Poster]

 

Kopanz, J; Libiseller, A; Lichtenegger, KM; De Campo, A; Wiesinger, T; Weidinger, L; Laubreiter, L; Schippinger, W; Truskaller, T; Augustin, T; Beck, P; Höll, B; Pieber, TR Efficacy, safety and usability of a basal insulin algorithm incorporated into a tablet-based workflow and decision support system (GlucoTab®) for glycemic management in patients with type 2 diabetes at an acute geriatric hospital
IAGG-ER. 2019; -IAGG-ER (INTERNATIONAL ASSOCIATION OF GERONTOLOGY AND GERIATRICS EUROPEAN REGION CONGRESS); MAY 23-25; Gothenburg, SWEDEN. [Poster]

 

Leitner, L; Bratschitsch, G; Amerstorfer, F; Smolle, M; Posch, F; Leithner, A; Challenges of Thesis Supervision in Medicine: How Candidates grade Organization and Didactics and what should be improved.
Symposium: Interprofessional Education in Health Sciences. 2019; -23nd Graz Conference; APR 26, 2019; Vienna. (ISBN: 978-3-200-06328-0 ) [Poster]

 

Moik, F; Posch, F; Grilz, E; Scheithauer, W; Pabinger, I; Prager, G; Ay, C Haemostatic Biomarkers for Prediction of Therapy Response and Prognosis of Disease in Patients with Metastatic Colorectal Cancer.
Research and Practice in Thrombosis and Haemostasis. 2019; 3(S1):187-188.-Congress of the International Society on Thrombosis and Haemostasis (ISTH) 2019; JUL 6-10, 2019; Melbourne, Australia;. [Oral Communication]
FullText

 

Perakis, S; Ulz, P; Riedl, JM; Scheipner, L; Kashofer, K; Höfler, G; Geigl, JB; Speicher, MR; Heitzer, E; Gerger, A Molecular-biological tumor profiling for drug treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage phase II individualized cancer treatment study
The Next Generation of Clinical Trials in Molecularly Driven Therapy. 2019; -AACR; MAR 29-APR 3, 2019; Atlanta, Georgia, USA. [Oral Communication]

 

Pohn, B ; Mayer, MC ; Reihs, R ; Holzinger, A ; Zatloukal, K ; Müller, H Visualization of Histopathological Decision Making Using a Roadbook Metaphor.
Proceedings of the 2019 23rd International Conference Information Visualisation (IV). 2019; 392-397.-2019 23rd International Conference Information Visualisation (IV); 2-5 July 2019; Paris, France, France. (ISBN: 978-1-7281-2838-2 ) [Oral Communication]
FullText

 

Pondorfer, P; Mollnar, S; Kasparek A; Reinisch, S; Moik, F; Stolz, M; Halm, M; Szkandera, J; Gerger; A; Kapp, K; Partl, R; Vasicek, S; Weiland, T; Pichler, M; Störer, H; Posch, F; Thurnher, D; Induction chemotherapy and chemoradiation for patients with advanced HNSCC: A systematic analysis of acute treatment toxicities and their management
https://www.hno.at/fileadmin/userdaten/HNO_Kongress_2019/HNO2019_Abstractband_web_20190828.pdf. 2019; -Österreichischer HNO Kongress; Sep 11-15, 2019; Salzburg. [Oral Communication]
FullText

 

Prinz, F; Reicher, A; Kiesslich, T; Klec, C; Gerger, A; Stoeger, H; Posch, F; Pichler, M Influence of epithelial-mesenchymal transition on immune checkpoints in biliary tract cancer
Doctoral Day of the Medical University Graz. 2019; -Doctoral Day of the Medical University Graz; NOV 21, 2019; Graz, AUSTRIA. [Poster]

 

Reicher, A; Prinz, F; Klec, C; Stoeger, H; Moik, F; Posch, F; Pichler, M Characterization of the fundamental role of fibroblast growth factor receptor 2 (FGFR2) gene fusions in carcinogenesis of intrahepatic cholangiocarcinoma using CRISPR/Cas9 genome engineering.
OEGHO- & AHOP-Frühjahrstagung 2019. 2019; -OeGHO- & AHOP-Frühjahrstagung 2019; 11.-13.April, 2019; Linz, AUSTRIA. [Poster]

 

Riedl, J; Stelzl, A; Aziz, F; Smolle, M; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stöger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Sourij, H; Szkandera, J Elevated mean glucose level predicts decreased disease free survival in soft tissue sarcoma patients.
32nd Annual Meeting of the European Musculo Skeletal Oncology Society. 2019; -32nd Annual Meeting of the European Musculo Skeletal Oncology Society; MAY 15-17, 2019; Florence, ITALY . [Poster]
FullText

 

Seles, M; Fillafer, F; Posch, F; Terzic, J; Pichler, M; Hutterer, GC; Zigeuner, R; Pummer, K; Bauernhofer, T. Lymphopenia can help to predict response to targeted 1st-line therapy in patients with metastatic renal cell carcinoma.
Europ Urolog Supplements. 2019; -Prize Winner Session at 34th Annual Congress of the European Association of Urology.; MAR 15-19; Bracelona, SPAIN. [Oral Communication]

 

Seles, M; Foßelteder, J; Slaby, O; Klec, C; Mischinger, J; Hutterer, G; Pummer, K; Pichler, M Identifikation und Charakterisierung einer neuen langen, nicht-kodierenden RNA RCA-lnc-RNA1 beim Nierenzellkarzinom
Der Urologe 2019, 58 (Suppl 1):S94/95.. 2019; -71. Kongress der Deutschen Gesellschaft für Urologie e.V.; SEP 18-21, 2019; Hamburg Messe, Deutschland. [Oral Communication]

 

Seles, M; Foseltseder, J; Mischinger, J; Klec, C; Slaby, O; Hutterer, GC; Pummer, K; Zigeuner, R; Pichler, M. Identification and characterization of a novel long non-coding RNA RCA-lncRNA1 in clear cell renal cell carcinoma
European Urology Supplements . 2019; 18(2):e2349--CEM19: 19th Central European Meeting in conjunction with the Austrian Association of Urology and the Bavarian Society of Urology ; 2019-05-10; Vienna, Austria. [Oral Communication]
FullText

 

Seles, M; Foseltseder, J; Mischinger, J;Klec, C; Slaby, O; Hutterer, GC, Zigeuner, R; Pummer, K; Pichler, M P Identifikation und Charakterisierung der neuen langen,nicht-kodierenden RNA RCA-lnc-RNA1
German Medical Science GMS Publishing House; 2019. Doc19oegu091 . 2019; -45. Gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und Andrologie und der Bayerischen Urologenvereinigung; MAY9-11 2019; Vienna, Austria. [Oral Communication]
FullText

 

Smolle, MA; Schaffler, A; Leithner, A; van Praag, VM; Bergovec, M; Szkandera, J; Liegl-Atzwanger, B; Niethard, M; Tunn, PU; van de Sande, M; Andreou D Incidence and outcome of abdominal metastases in soft tissue sarcoma. Results of a multicentre study.
Abstract Book of the 32. Annual Meeting of the European Musculoskeletal Tumour Society (EMSOS). 2019; -32. Annual Meeting of the European Musculoskeletal Tumour Society (EMSOS); MAY 15-17, 2019; Florence, ITALY. [Oral Communication]

 

Smolle, MA; van de Sande, M; Callegaro, D; Wunder, J; Hayes, AJ; Leitner, L; Bergovec, M; Tunn, PU; van Praag, VM; Panotopoulos, J; Willegger, M; Windhager, R; Riedl, JM; Stotz, M; Gerger, A; Pichler, M; Stöger, H; Liegl-Atzwanger, B; Smolle, J; Leithner, A; Gronchi, A; Haas, RL; Szkandera, J Advancing soft-tissue sarcoma aftercare using flexible parametric survival models.
Abstract Book of the 32. Annual Meeting of the European Musculoskeletal Tumour Society (EMSOS). 2019; -32. Annual Meeting of the European Musculoskeletal Tumour Society (EMSOS); MAY 15-17, 2019; Florence, ITALY. [Oral Communication]

 

Smolle, MA; van de Sande, M; Callegaro, D; Wunder, J; Hayes, AJ; Leitner, L; Bergovec, M; Tunn, PU; van Praag, VM; Panotopoulos, J; Willegger, M; Windhager, R; Riedl, JM; Stotz, M; Gerger, A; Pichler, M; Stöger, H; Liegl-Atzwanger, B; Smolle, J; Leithner, A; Gronchi, A; Haas, RL; Szkandera, J Individualising soft tissue sarcoma aftercare with flexible parametric survival modelling.
Webabstracts of the 20th General Meeting of the International Society of Limb Salvage (ISOLS). 2019; -20th General Meeting of the International Society of Limb Salvage (ISOLS); SEP 11-14, 2019; Athens, GREECE. [Oral Communication]

 

Szkandera, J Welche Therapien für welche molekularen Subgruppen?
Oncol Res Treat 2019;42(suppl 4):1-33610.1159/000502425. 2019; -DGHO; OCT 11-14, 2019; Berlin, GERMANY. [Oral Communication]

 

Trenk, C; Prinz, F; Resel, M; Stoeger, H; Klec, C; Pichler, M miR-4520s as potential regulator of breast carcinogenesis
Doctoral Day 2019. 2019; -Doctoral Day 2019, Medical University of Graz; NOV 21, 2019; Graz, AUSTRIA. [Poster]

 

Valentin, A; Wichmann, H; Neugebauer, K; Krippl, P; Krause, R; Valentin, T Nomen est omen: acute haemolytic anaemia in a patient with persistent Staphylococcus haemolyticus bacteraemia associated with intravascular foreign material
http://www.oeginfekt.at/download/13_oeik_programm_2019_v5.pdf. 2019; -13. Österreichischer Infektionskongress ; MAR 27-30, 2019; Saalfelden am Steinernen Meer. [Poster]
FullText

 

Vosberg, S; Kerbs, P; Jurinovic, V; Metzeler, KH; Amler, S; Sauerland, C; Görlich, G; Berdel, WE; Braess, J; Hiddemann, W; Spiekermann, K; Herold, T; Greif, PA DNA methylation profiling of AML reveals epigenetic subgroups with distinct clinical outcome.
Blood. 2019; 134: -61st Annual Meeting of the American Society of Hematology; DEC 11-14, 2019; Orlando, USA. [Poster]
FullText

 

Sonstige Veröffentlichungen

Terzic J; Bauernhofer T Biomarkers in renal cell carinoma
memo 12, 342–346 (2019). . 2019
FullText

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum